Operating Segment Information (Tables)

12 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, for the years ended September 30, as follows (in thousands):

	2015			2014			2013
Revenue:
Medical Device	$	45,944		$	43,068		$	41,153
In Vitro Diagnostics		15,954			14,371			14,979
Total revenue	$	61,898		$	57,439		$	56,132
Operating income (loss):
Medical Device	$	21,192		$	22,636		$	21,164
In Vitro Diagnostics		4,484			3,459			4,222
Total segment operating income		25,676			26,095			25,386
Corporate		(6,587	)		(7,519	)		(6,566	)
Total operating income from continuing operations	$	19,089		$	18,576		$	18,820
Depreciation and amortization:
Medical Device	$	1,138		$	1,136		$	1,255
In Vitro Diagnostics		873			850			864
Corporate		794			729			767
Total depreciation and amortization	$	2,805		$	2,715		$	2,886

Revenue from Major Customers

Revenue from customers that equaled or exceeded 10% of total revenue was as follows for the years ended September 30:

	2015			2014			2013
Medtronic		26	%		19	%		19	%

Geographic Revenue

Geographic revenue was as follows for the years ended September 30:

	2015			2014			2013
Domestic		77	%		78	%		79	%
Foreign		23	%		22	%		21	%